Yevgeniy (“Eugene”) R. Semenov, MD, MA is a board-certified dermatologist and Assistant Professor in Dermatology at Harvard Medical School with extensive experience in clinical informatics, health economics, and public health research.  He received his bachelor’s in Applied Mathematics & Statistics, master’s in Applied Economics, and medical degrees from Johns Hopkins University. After graduating from medical school, Dr. Semenov pursued an internship in internal medicine at Mercy Medical Center in Baltimore, MD and residency training in Dermatology at Washington University School of Medicine in St. Louis, MO.

Dr. Semenov’s clinical expertise includes cutaneous oncology with a focus on melanoma and supportive oncodermatology. His research interests include epidemiology of melanoma and non-melanoma skin cancer with an emphasis on improving outcomes and treatment selection for patients with advanced disease. As part of this clinical and research focus, Dr. Semenov provides care to patients experiencing skin side effects from chemotherapy and immunotherapy used for the management of advanced cancers.

He has published more than 70 papers in leading dermatologic and oncologic publications, including the Journal of the American Academy of Dermatology, Journal of the American Medical Association Dermatology, Journal of Investigative Dermatology, British Journal of Dermatology, Journal for Immunotherapy of Cancer, and the Journal of the National Cancer Institute. His research has established robust multi-institutional and population-level evidence on the epidemiology, treatment options, and downstream outcomes for cutaneous immunotherapy toxicities.

Dr. Semenov is fluent in English and Russian.   Dr. Semenov sees patients in our Boston location and at the MGH Cancer Center.